Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Currency in USD	2026
Operating Income	72.60 Million
Income Before Tax	542.10 Million
Income Tax Expense	170.70 Million
Net Income	371.40 Million
Eps	13.89
Epsdiluted	13.85
Weighted Average Shs Out	26.75 Million
Weighted Average Shs Out Dil	26.81 Million
Research And Development Expenses	61.20 Million
Selling General And Administrative Expenses	212.00 Million
Depreciation And Amortization	41.10 Million
Interest Expense	12.10 Million
Interest Income	22.30 Million
Net Interest Income	10.20 Million
Premiums Earned	N/A
Policyholder Benefits	N/A
Gross Profit	345.80 Million
Ebitda	113.70 Million
Source	edgar
Ebit	554.20 Million

Bio-Rad Laboratories, Inc. Annual Reports (10-K)